|
B-Cell Lymphomas Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 115 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on the B-Cell Lymphomas clinical trial scenario. This report provides element.....
Introduction GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on the B-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 B-Cell Lymphomas 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of B-Cell Lymphomas 25 Subjects Recruited Over a Period of Time 31 Prominent Sponsors 32 Top Companies Participating in B-Cell Lymphomas Therapeutics Clinical Trials 34 Prominent Drug Comparison 36 Clinical Trial Profiles 37 Clinical Trial Overview of Top Companies 37 F. Hoffmann-La Roche Ltd. 37 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37 Pfizer Inc. 39 Clinical Trial Overview of Pfizer Inc. 39 GlaxoSmithKline plc 40 Clinical Trial Overview of GlaxoSmithKline plc 40 Celgene Corporation 41 Clinical Trial Overview of Celgene Corporation 41 Eli Lilly and Company 42 Clinical Trial Overview of Eli Lilly and Company 42 Millennium Pharmaceuticals, Inc. 43 Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 43 Takeda Pharmaceutical Company Limited 44 Clinical Trial Overview of Takeda Pharmaceutical Company Limited 44 Novartis AG 45 Clinical Trial Overview of Novartis AG 45 Sanofi 46 Clinical Trial Overview of Sanofi 46 Pharmacyclics, Inc. 47 Clinical Trial Overview of Pharmacyclics, Inc. 47 SymBio Pharmaceuticals Limited 48 Clinical Trial Overview of SymBio Pharmaceuticals Limited 48 Biogen Idec Inc. 49 Clinical Trial Overview of Biogen Idec Inc. 49 Merck & Co., Inc. 50 Clinical Trial Overview of Merck & Co., Inc. 50 Cephalon, Inc. 51 Clinical Trial Overview of Cephalon, Inc. 51 Cell Therapeutics, Inc. 52 Clinical Trial Overview of Cell Therapeutics, Inc. 52 Seattle Genetics, Inc. 53 Clinical Trial Overview of Seattle Genetics, Inc. 53 MedImmune, LLC 54 Clinical Trial Overview of MedImmune, LLC 54 AstraZeneca PLC 55 Clinical Trial Overview of AstraZeneca PLC 55 Amgen Inc. 56 Clinical Trial Overview of Amgen Inc. 56 IMMUNOMEDICS, INC 57 Clinical Trial Overview of IMMUNOMEDICS, INC 57 Clinical Trial Overview of Top Universities / Institutes / Hospitals 58 Fred Hutchinson Cancer Research Center 58 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 58 The University of Texas M. D. Anderson Cancer Center 62 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 62 Dana-Farber Cancer Institute 64 Clinical Trial Overview of Dana-Farber Cancer Institute 64 Groupe d'Etudes de Lymphomes de L'Adulte 66 Clinical Trial Overview of Groupe d'Etudes de Lymphomes de L'Adulte 66 Southwest Oncology Group 68 Clinical Trial Overview of Southwest Oncology Group 68 Mayo Clinic 70 Clinical Trial Overview of Mayo Clinic 70 Duke University 71 Clinical Trial Overview of Duke University 71 City of Hope National Medical Center 72 Clinical Trial Overview of City of Hope National Medical Center 72 Weill Cornell Medical College 73 Clinical Trial Overview of Weill Cornell Medical College 73 Memorial Sloan Kettering Cancer Center 74 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 74 Massachusetts General Hospital 75 Clinical Trial Overview of Massachusetts General Hospital 75 Groupe d Etude des Lymphomes de l Adulte 76 Clinical Trial Overview of Groupe d Etude des Lymphomes de l Adulte 76 UCLA's Jonsson Comprehensive Cancer Center 77 Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 77 Sarah Cannon Research Institute 78 Clinical Trial Overview of Sarah Cannon Research Institute 78 Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS 79 Clinical Trial Overview of Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS 79 Swiss Group for Clinical Cancer Research 80 Clinical Trial Overview of Swiss Group for Clinical Cancer Research 80 University of Wisconsin Madison 81 Clinical Trial Overview of University of Wisconsin Madison 81 Stanford University 82 Clinical Trial Overview of Stanford University 82 H. Lee Moffitt Cancer Center & Research Institute 83 Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 83 Case Comprehensive Cancer Center 84 Clinical Trial Overview of Case Comprehensive Cancer Center 84 Five Key Clinical Profiles 85 Appendix 112 Abbreviations 112 Definitions 112 Research Methodology 113 Secondary Research 113 About GlobalData 114 Contact Us 114 Disclaimer 114 Source 115 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15 B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 B-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries, 2012* 17 B-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries, 2012* 18 B-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 B-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries, 2012* 20 B-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 B-Cell Lymphomas Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25 B-Cell Lymphomas Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26 B-Cell Lymphomas Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27 B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31 B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33 B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35 B-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 37 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 39 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 40 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 41 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 42 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012* 43 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 44 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 45 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 46 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012* 47 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by SymBio Pharmaceuticals Limited, 2012* 48 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012* 49 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 50 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012* 51 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Therapeutics, Inc., 2012* 52 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2012* 53 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012* 54 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 55 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 56 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by IMMUNOMEDICS, INC, 2012* 57 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 58 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 62 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 64 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etudes de Lymphomes de L'Adulte, 2012* 66 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 68 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 70 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 71 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 72 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 73 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 74 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 75 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d Etude des Lymphomes de l Adulte, 2012* 76 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012* 77 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 78 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS, 2012* 79 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Group for Clinical Cancer Research, 2012* 80 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 81 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 82 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 83 B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 84 List of Figures B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15 B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 B-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 B-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 B-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 B-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 B-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31 B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32 B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34 B-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36 GlobalData Methodology 113 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
